 Yeah, we have precedent that agency actions aren't absolute, that in fact we can ask questions. That's why we have this arbitrary and capricious standard that we turn to when we're evaluating decision making. We know from the FDA's own documents that they ignored relevant studies, that they did not have a comprehensive study that would address all of their 2016 actions.